- Six-year trend of poorer health outcomes and worsening inequalities in access to diabetes technology in children and young people with type 1 diabetes
- Children of black ethnicity with type 1 diabetes are more likely to have higher blood sugar levels (HbA1c) and use diabetes technology less than children from any other ethnic group.
- The UK has the largest prevalence of type 1 diabetes in children and young people in Europe
Immediate action from government is required to address the disparity in access to life-changing diabetes technologies, leading charity Diabetes UK has said today in response to a new report.
Findings from The National Paediatric Diabetes Audit (NPDA) show widening inequalities in the care of children and young people with type 1 diabetes in England and Wales for the 6th year. These include poorer diabetes outcomes and worsening access to diabetes technology in children and young people from ethnic minority backgrounds and socially deprived areas.
The NPDA reveals that:
- Children and young people with type 1 diabetes from ethnic minority backgrounds are more likely to have higher average blood sugar levels (HbA1c) compared to White children.
- Black children and young people have the highest average HbA1c levels, followed by children with a Mixed ethnic background and Asian children respectively.
- Children in the most deprived areas are more likely to have higher average blood sugar levels (HbA1c) compared to those in the least deprived areas.
A high HbA1c level means too much sugar in the blood over time. This increases the risk of developing serious complications, such as kidney failure, eye and foot problems, heart attacks and stroke.
Diabetes technologies such as insulin pumps and Continuous Glucose Monitors (CGMs) help people with diabetes to manage their condition, including HbA1c, and have been shown to improve health and wellbeing. And while the NPDA reports an overall upward trend in the use of diabetes technologies, technology use is lowest in children and young people from socially deprived areas and from ethnic minority communities.
Specifically, the NPDA shows that:
- The gap between children using an insulin pump in the most and least deprived areas has widened from 7.9% in 2014/15, to 12.6% in 2019/20.
- There is significantly lower use of insulin pumps and CGMs in Black children compared to White children, who have the highest use of diabetes technology.
A total of 27,653 children and young people in the UK have type 1 diabetes according to the NPDA – the highest prevalence in Europe.
There is limited research exploring why these inequalities exist in the UK. But there is clear action that can be taken now, which is why Diabetes UK believes tackling the issue of unequal access to diabetes technologies, and the wider issue of health inequalities in diabetes care needs to be fought on two fronts:
- By government providing urgent funding to break the postcode lottery that today causes significant variation in access to diabetes technology depending on where a person lives, their level of deprivation and their ethnicity, and
- By government and funders committing to support research to help understand why these inequalities exist, and what can be done to address them.
To support this, Diabetes UK is working with leading diabetes researchers through its Diabetes Research Steering Groups, and in partnership with JDRF, to develop research to reveal barriers to equal access to diabetes technology. In the longer term this work will help identify targeted interventions to address this 6-year trend of widening inequalities.
While the research needed to understand the root causes of these issues will take time and commitment from government and funders to happen, ending the postcode lottery is something that can be addressed today. That is why Diabetes UK is urging the Government to take immediate action to ensure that every child and young person can access diabetes technology regardless of where they live.
Chris Askew OBE, Chief Executive at Diabetes UK, said:
“It is unacceptable that children and young people from ethnic minority communities and socially deprived areas have poorer diabetes-related outcomes and lower usage of diabetes technology. We need to understand precisely why these children and young people face such stark and widening inequalities to help address and solve the problem for future generations.
“But what we can do now is ensure that diabetes technology is made available to all children and young people who meet the eligibility criteria.
“This funding would save children with diabetes and their families from distress that nobody should have to face, and could help reduce hospital admissions from preventable complications. It is vital that the Government gives all people with diabetes the tools they need, today.”
A/Professor May Ng, Chair of the Diabetes Research Steering Group focused on Children & Young People who is leading the efforts to drive forward research in this area, said:
“While this year’s NPDA reports that use of Continuous Glucose Monitoring (CGM) and insulin pump technology is associated with better HbA1c outcomes, even when other factors are adjusted – it is very concerning that inequalities in health outcomes have grown, and the use of technologies in children with diabetes living in the most deprived areas and of ethnic minority backgrounds were faring worse. This disparity has widened over the last 6 years.
“For example, the gap between insulin pump and CGM usage amongst children from an ethnic minority backgrounds and those living in the most and least deprived areas has widened with time from 2014 to 2020. We should be looking at why this is happening and how we should be reducing variations in care. It is time for everyone to act now.”
Karen Addington, UK Chief Executive of the type 1 diabetes charity JDRF, said:
“The latest NPDA findings paint a dire picture of inequality among children and young people with type 1 diabetes. Wearable medical technologies for managing type 1 diabetes can improve lives and clinical outcomes, yet children and young people from ethnic minority communities and socially deprived areas are particularly missing out.
“Everybody who wants and needs access to type 1 diabetes technology should receive it, which is why we’re calling for more to be done to reach people with type 1 from these groups. We’re working in partnership with Diabetes UK to understand the barriers, many of which were identified in our 2020 Pathway to Choice report, and call on the Government and local NHS bodies to work with us to overcome them.”